ALKERMES | ALKS - Trade Creditors


ALKERMES reported $142.86M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
ALKERMES USD 142.86M 40.5M Jun/2026
Amgen USD 19.52B 1.37B Mar/2026
Biogen USD 403.9M 45.4M Jun/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Malin Corporation EUR 700K 200K Dec/2024
Merck USD 3.86B 541M Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Otsuka Holdings JPY 216.64B 20.6B Jun/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pfizer USD 4.58B 75M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026